This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dalerba, P. et al. CDX2 as a prognostic biomarker in stage II and stage III colon cancer. N. Engl. J. Med. 374, 211–222 (2016)
Rights and permissions
About this article
Cite this article
Hutchinson, L. CDX2: prognostic marker for high-risk colon cancer. Nat Rev Clin Oncol 13, 134–135 (2016). https://doi.org/10.1038/nrclinonc.2016.18
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2016.18